|
Volumn 43, Issue 11, 2000, Pages 2488-2492
|
Evaluation of antineutrophil cytoplasmic antibody seroconversion induced by minocycline, sulfasalazine, or penicillamine
a b a a a c |
Author keywords
[No Author keywords available]
|
Indexed keywords
MINOCYCLINE;
NEUTROPHIL CYTOPLASMIC ANTIBODY;
PENICILLAMINE;
SALAZOSULFAPYRIDINE;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
HUMAN;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RHEUMATOID ARTHRITIS;
SEROCONVERSION;
VASCULITIS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC;
DOUBLE-BLIND METHOD;
MINOCYCLINE;
PENICILLAMINE;
SULFASALAZINE;
VASCULITIS;
|
EID: 0033763408
PISSN: 00043591
EISSN: None
Source Type: Journal
DOI: 10.1002/1529-0131(200011)43:11<2488::AID-ANR16>3.0.CO;2-X Document Type: Article |
Times cited : (51)
|
References (23)
|